Magnetic Needle Performs Less Invasive, More Precise Surgery and Diagnostic Tests
|
By LabMedica International staff writers Posted on 25 Apr 2022 |

A tiny, untethered needle can enter the body through an incision no larger than a pin prick to perform biopsies, suture wounds, and even deliver cancer-fighting chemotherapy directly to tumors. Controlled by externally applied magnetics forces—no attached, guiding wires, or human or robotic hands—these miniscule tools promise a future of more precise, safer, and far less invasive surgery, experts say. However, as devices get smaller, so does their response to the magnetic forces that cause them to move and steer their course. Now, researchers have a solution: a surgical needle equipped with small magnets inside that, when stimulated by the externally applied forces, slip from one end of the needle to another, tapping against a rigid plate and supplying ample force to penetrate tissue.
In a study, a team of researchers at the Johns Hopkins Whiting School of Engineering (Baltimore, MD, USA) have demonstrated for the first time that untethered magnetic needles can be forceful enough to accomplish surgery. The researchers call their device the "Pulse Actuated Collisions for Tissue-penetrating Needle," or MPACT-Needle. For their experiments, the team connected a slender thread of suturing material to the needle, using a joystick connected to a computer to deliver commands that enabled the MPACT-Needle to perform surgical suturing on a sample rabbit cornea.
The team's next step is to develop better, more accurate motion-control algorithms equipped with imaging modalities to precisely control the movement of the device, making surgeries and procedures safer. The researchers believe that if the technology becomes successful, their new magnetic needles would make it possible to access hard-to-reach, delicate areas of the body, such as the bile duct, to deliver drugs directly to tumors, extract biopsy samples, or suture a wound rapidly and effectively to stem internal bleeding.
"These extremely small tools have the potential to revolutionize medicine, but as anyone who has played with magnets knows, size is important," said Axel Krieger, an assistant professor of mechanical engineering at Johns Hopkins Whiting School of Engineering. "The smaller the surgical tool, the less invasive the surgery, but also the weaker the device's response to magnetic force. One of the biggest challenges facing us is how to make sure that these mini-tools can be moved with enough force to penetrate tissue and do the job they are there to do."
"We proved that these tiny magnetic needles can have strong enough forces to perform delicate surgery with limited invasiveness," said study leader Onder Erin, a postdoctoral fellow in mechanical engineering at Johns Hopkins. "I can envision a time when our device will also be used to perform biopsies, and even deliver therapeutics and chemotherapy directly to tumors."
Related Links:
Johns Hopkins Whiting School of Engineering
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read more
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
AI Tool Improves Accuracy of Cancer Liquid Biopsy for Therapy Selection
Liquid biopsy is increasingly used to guide targeted therapy by detecting tumor-derived mutations in blood, but distinguishing true tumor signals from background noise remains challenging.... Read more
Study Highlights Inherited Breast Cancer Risk Genes in Young Black Women
Early-onset breast cancer remains a significant concern, with some cases presenting as triple-negative disease, one of its most aggressive forms. Black women face disproportionately elevated risks of developing... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
Congenital TORCH infections can be asymptomatic during pregnancy yet cause stillbirth, birth defects, and lifelong disability in infants. Many regions still lack robust surveillance to guide testing and... Read more
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read morePathology
view channel
AI Pathology Tool Predicts Meningioma Recurrence from Routine Slides
Meningiomas are the most common primary brain tumors in adults, yet their course ranges from indolent to highly recurrent disease. Estimating an individual patient’s recurrence risk often requires advanced... Read more
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Genetic Testing Program Expands Detection of Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency (AATD) is a progressive genetic condition, the leading known genetic risk factor for chronic obstructive pulmonary disease (COPD), and a cause of liver disease in both children... Read more








